Full Text View  
  Tabular View  
  Contacts and Locations  
  Study Results  
  Related Studies  
Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections (SSI2)
This study has been completed.
Sponsors and Collaborators: Swiss Tropical Institute
Swiss Academy of Medical Sciences (SAMS)
Information provided by: Swiss Tropical Institute
ClinicalTrials.gov Identifier: NCT00801099
  Purpose

In a rural hospital in Tanzania the rate of surgical site infections (SSI) was 21.6%. Inappropriate choice of antibiotics and of administration time were determined as sole risk factors in this setting. After implementation of a standardized procedure with a single shot dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively the rate of SSI dropped by 80% in spite of procedural risk factors like poor hygiene etc.


Condition Intervention
Surgical Site Infection
Drug: Amoxicillin/Clavulanic Acid

MedlinePlus related topics: Antibiotics
Drug Information available for: Amoxicillin Amoxicillin sodium Amoxicillin trihydrate Amoxicillin-potassium clavulanate combination Clavulanic acid
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study
Official Title: Benefit of a Single Preoperative Dose of Antibiotics in a Sub-Saharan District Hospital: Minimal Input, Massive Impact

Further study details as provided by Swiss Tropical Institute:

Primary Outcome Measures:
  • Number of Participants With Surgical Site Infections [ Time Frame: within 30 days postoperative ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Sustainability of the Intervention in This Setting [ Time Frame: during 3 month of study phase ] [ Designated as safety issue: Yes ]

Enrollment: 276
Study Start Date: December 2004
Study Completion Date: March 2005
Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Abx: Experimental
single shot dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively
Drug: Amoxicillin/Clavulanic Acid
single shot dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively

Detailed Description:

Surgical Site Infections (SSIs) have an important socioeconomic impact prolonging the period of hospitalization and rehabilitation. Patients with SSIs are five times more likely to be readmitted and are even twice as likely to die compared to patients with similar interventions without SSI. In non-industrialized countries, the incidence of SSIs is higher and the consequences of SSI are even more severe: Many hospitals lack appropriate facilities for early diagnosis and treatment. In addition, microbiological identification of pathogens and susceptibility testing are rarely available, a prerequisite for targeted treatment of SSIs. Overcrowding and understaffing are additional risk factors for SSIs, common in these countries.

A study conducted at the local surgeons' suggestion in an 82-bed department of general surgery, obstetrics and gynecology, urology and orthopedics at the St. Francis Designated District Hospital (SFDDH) in Ifakara (Southern Tanzania) showed an SSI-rate of 21.6%.

The analyses of this study identified two major risk factors for SSI in clean and clean-contaminated surgical procedures: Inadequate timing of administration of routine antimicrobial prophylaxis (AMP) and inappropriate selection of antibiotics not covering the most commonly observed pathogens.

Therefore, an intervention study was discussed with the local surgeon in charge to improve selection and timing of routine AMP and thereby reduce the rate of SSIs.

The study design and objective were presented to all the staff during a general meeting and special duties and responsibilities discussed with the individual colleagues. Furthermore we distributed pocket flow sheets to the involved staff and hung up some laminated flow sheets in theatre.

  Eligibility

Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • surgical patient
  • clean or clean-contaminated surgery

Exclusion Criteria:

  • infection
  • preoperative antibiotic treatment
  • postoperative antibiotic treatment
  • open fractures
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00801099

Locations
Switzerland, BS
Swiss Tropical Institute
Basel, BS, Switzerland, 4001
Sponsors and Collaborators
Swiss Tropical Institute
Swiss Academy of Medical Sciences (SAMS)
Investigators
Study Chair: Christioph F Hatz, MD Swiss Tropical Institute
  More Information

Responsible Party: Department of Medicine and Diagnostics, Swiss Tropical Institute ( Prof. Dr. med. C. Hatz )
Study ID Numbers: SSII
Study First Received: November 6, 2008
Results First Received: November 6, 2008
Last Updated: January 13, 2009
ClinicalTrials.gov Identifier: NCT00801099  
Health Authority: Switzerland: Ethikkommission;   Tanzania: National Institute for Medical Research

Keywords provided by Swiss Tropical Institute:
Postoperative wound infection
surgical site infection
antimicrobial prophylaxis
developing countries
Sub-Saharan Africa
reduction of SSI using preoperative antibiotics

Study placed in the following topic categories:
Amoxicillin
Clavulanic Acid
Clavulanic Acids
Surgical Wound Infection
Amoxicillin-Potassium Clavulanate Combination
Wound Infection

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Bacterial Agents
Communicable Diseases
Molecular Mechanisms of Pharmacological Action
Therapeutic Uses
Enzyme Inhibitors
Infection
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009